Indian Journal of Pharmacy Practice logo
Article

A prospective study comparing Total Lymphocyte Count (TLC) and CD4 counts in HIV patients in a resource limited setting in India

1, 2, 3, 4

  1. 1Pharmcoeconomic Research Specialist, Drug Use Policy and Pharmacoeconomics, UT MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 706, Houston, Texas 77030.
  2. 2Manager-Clinical Pharmacy, HCG Towers, P.Kalinga Rao Road, Bangalore-27, Karnataka, INDIA.
  3. 3Asso. Professor, College of Pharmaceutical sciences, Medical college, Thiruvananthapuram, Kerala, INDIA.
  4. 4Prof & Head, Dept. Of Medicine, Medical college Hospital, Thiruvananthapuram, Kerala, INDIA.

CORRESPONDENCE

Lincy Lal

Pharmcoeconomic Research Specialist, Drug Use Policy and Pharmacoeconomics, UT MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 706, Houston, Texas 77030.

llal@mdanderson.org

Received: 09-09-2008; Accepted: 23-09-2008.

Volume 2, Issue 1 · pp. 28-35 · 2009 · DOI:

ABSTRACT

Even after 25 years of the first detection of AcquiredImmunodeficiency Syndrome (AIDS), it remains a major health care problem without any cure. Extensive research around the world and the subsequent introduction of highly active antiretroviral therapy (HAART) has produced dramatic reduction on morbidity, mortality and health care utilization. HAART regimens have revolutionized the treatment of human immunodeficiency virus (HIV), which consistently results in sustained suppression of HIV-1 RNA replication, resulting in gradual increases in CD4 T lymphocyte count, sometimes to normal levels.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Lal, L., George, C., Yesoda, A., & B, J. (2009). A prospective study comparing Total Lymphocyte Count (TLC) and CD4 counts in HIV patients in a resource limited setting in India. Indian Journal of Pharmacy Practice, 2(1), 28-35.

    Copyright and licence

    © 2009 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0